Paradigm Biopharmaceuticals Ltd.ASX: PAR

PARs Osteoarthritis Phase 2 Receives Ethics Approval

Sep 19, 2017 at 2:55 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment